sharecast

{{ storiesRelated.title }}

Company News
26 Feb
dl hipgnosis songs fund music intellectual property ip songwriting investing catalogue logo ftse 250
Hipgnosis Songs Fund looks to secure indemnity from Merck Mercuriadis

Music royalties investor Hipgnosis Songs Fund said on Monday that it was now seeking to secure an indemnity from Merck Mercuriadis and Hipgnosis Songs Management following the issuance of High Court proceedings against both.

26 Feb
dl begbies traynor group plc aim financials financial services investment banking and brokerage services diversified financial services logo
Begbies Traynor maintains expectations, signs new debt facility

Professional services consultancy Begbies Traynor said in a trading update on Monday that it maintained consistency with expectations in the third quarter, with both divisions trading in accordance with the outlook it provided at its half-year results in December.

26 Feb
dl kosmos energy ltd lse energy energy oil gas and coal oil crude producers logo 20230509 0824
Kosmos Energy swings to Q4 profit despite fall in sales

American oil group Kosmos Energy reported that fourth-quarter revenues fell by a tenth as falling prices outweighed an increase in production, but the company swung to a profit and painted a bullish outlook for the coming year.

26 Feb
dl gsk plc gsk health care healthcare pharmaceuticals and biotechnology pharmaceuticals ftse 100 premium glaxosmithkline glaxo smith kline 20230328 1835
GSK reports positive results from gonorrhoea treatment trial

GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

26 Feb
dl hammerson retail property shopping centres footfall mall logo ftse 250
Hammerson to sell Aberdeen shopping centre for £111m

Hammerson said on Monday that it has agreed the sale of Aberdeen shopping centre Union Square to an affiliate of Lone Star Real Estate Fund VI for £111m in cash.

26 Feb
dl astrazeneca r
AstraZeneca's blood-disorder drug recommended for EU approval

European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.